Fibrates as Adjuvant Therapy for Chronic Cholestatic Liver Disease: Its Time Has Come

被引：28
作者：
Ghonem, Nisanne S. [1 ,2 ]
Boyer, James L.
机构：
[1] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Ctr Liver, New Haven, CT 06520 USA
来源：
HEPATOLOGY | 2013年 / 57卷 / 05期
关键词：
PRIMARY BILIARY-CIRRHOSIS; URSODEOXYCHOLIC ACID; BEZAFIBRATE TREATMENT; BIOCHEMICAL RESPONSE; COMBINATION THERAPY; FENOFIBRATE; RECEPTOR; EFFICACY;
D O I：
10.1002/hep.26155
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1691 / 1693
页数：3
相关论文
共 26 条
[1]   Lipid-activated transcription factors control bile acid glucuronidation [J].
Barbier, Olivier ;
Trottier, Jocelyn ;
Kaeding, Jenny ;
Caron, Patrick ;
Verreault, Melanie .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 326 (1-2) :3-8
[2]   Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome [J].
Corpechot, Christophe ;
Chazouilleres, Olivier ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2011, 55 (06) :1361-1367
[3]   THE EFFECT OF BEZAFIBRATE TREATMENT ON SERUM ALKALINE-PHOSPHATASE ISOENZYME ACTIVITIES [J].
DAY, AP ;
FEHER, MD ;
CHOPRA, R ;
MAYNE, PD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07) :839-842
[4]  
Dohmen K, 2004, WORLD J GASTROENTERO, V10, P894
[5]   No more pilots, a phase III trial of fibrates in primary biliary cirrhosis is long overdue! [J].
Halliday, John S. ;
Chapman, Roger W. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (09) :1345-1346
[6]   Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy [J].
Han, Xiao Feng ;
Wang, Qi Xia ;
Liu, Yuan ;
You, Zheng Rui ;
Bian, Zhao Lian ;
Qiu, De Kai ;
Ma, Xiong .
JOURNAL OF DIGESTIVE DISEASES, 2012, 13 (04) :219-224
[7]   Bezafibrate Treatment of Primary Biliary Cirrhosis Following Incomplete Response to Ursodeoxycholic Acid [J].
Hazzan, Rawi ;
Tur-Kaspa, Ran .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (05) :371-373
[8]   N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists.: 1.: Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents [J].
Henke, BR ;
Blanchard, SG ;
Brackeen, MF ;
Brown, KK ;
Cobb, JE ;
Collins, JL ;
Harrington, WW ;
Hashim, MA ;
Hull-Ryde, EA ;
Kaldor, I ;
Kliewer, SA ;
Lake, DH ;
Leesnitzer, LM ;
Lehmann, JM ;
Lenhard, JM ;
Orband-Miller, LA ;
Miller, JF ;
Mook, RA ;
Noble, SA ;
Oliver, W ;
Parks, DJ ;
Plunket, KD ;
Szewczyk, JR ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :5020-5036
[9]   Anticholestatic Effects of Bezafibrate in Patients with Primary Biliary Cirrhosis Treated with Ursodeoxycholic Acid [J].
Honda, Akira ;
Ikegami, Tadashi ;
Nakamuta, Makoto ;
Miyazaki, Teruo ;
Iwamoto, Junichi ;
Hirayama, Takeshi ;
Saito, Yoshifumi ;
Takikawa, Hajime ;
Imawari, Michio ;
Matsuzaki, Yasushi .
HEPATOLOGY, 2013, 57 (05) :1931-1941
[10]   The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study [J].
Iwasaki, Shinji ;
Ohira, Hiromasa ;
Nishiguchi, Shuhei ;
Zeniya, Mikio ;
Kaneko, Shuichi ;
Onji, Morikazu ;
Ishibashi, Hiromi ;
Sakaida, Isao ;
Kuriyama, Shigeki ;
Ichida, Takafumi ;
Onishi, Saburo ;
Toda, Gotaro .
HEPATOLOGY RESEARCH, 2008, 38 (06) :557-564
123